We built Journey to give more mental-health professionals access to psychedelic-assisted therapy.
There's a handoff that's going on: A doctor will send the patient to a ketamine therapist, or to a clinic, or to a platform that sends the person the ketamine and they do it alone.
You're being asked to go do something very personal with someone you never met, and then you have to bring that back to this therapist who doesn't necessarily have the experience of working with these treatments. It doesn't make sense.
That's why we built Journey. Our understanding is that in order to enable mainstream adoption of psychedelic-assisted psychotherapy, we have to empower licensed mental-health professionals to incorporate them in their practice as an adjunct.